Difference between revisions of "Pharm Meeting Minutes 2021.03.17"

From IHE Wiki
Jump to navigation Jump to search
Line 16: Line 16:
** Jose Costa Teixeira
** Jose Costa Teixeira
** Michael Tan
** Michael Tan
** Jurgen Brandstatter
** Jacqueline Surugue

Revision as of 07:20, 17 March 2021

Meeting details


Session 1 Login for Teams
Session 2 Login for Teams


Q1 13:00- 14:30 Change proposals & Medication Lists

  • Participants:
    • Leonidas Tzimis
    • Stephane Spahni
    • Jose Costa Teixeira
    • Michael Tan
    • Jurgen Brandstatter
    • Jacqueline Surugue

Change Proposals

  • Switzerland has recently organized a projectathon. A third projectathon is planned. This includes CDA and FHIR profiles.

Overview: CP Overview

  • CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
  • CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
    • Dose and rate quantity is herited from PCC. Is it a quantity or a range. Which unit is allowed.There is a difference with PCC definition.
  • CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
    • Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction

For information only:

  • CP-ITI-xxx "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
  • CP-PCC-xxx Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles

Medication lists

14:30- 15:00 Break

Q2 15:00- 16:30 Vaccination Topics


Work items

Logical Model

  • WHO model
  • European Model
  • Belgian Model
  • German Model
  • The IHE Pharmacy material can be found here:




  • the WHO FHIR material can be found in Github.



Pharmacy Technical Committee